Tablet Manufacturing Troubleshooting

Tablet manufacturing problems, though outwardly diverse, generally trace back to a relatively small set of underlying physical or formulation causes, and...

Tablet manufacturing problems, though outwardly diverse, generally trace back to a relatively small set of underlying physical or formulation causes, and effective troubleshooting requires systematically working backward from an observed defect to its most probable root cause. Capping and lamination, in which the tablet crown separates partially or completely from the body of the tablet, most commonly arise from over-dried granules with insufficient residual moisture to support inter-particulate bonding, an excessive proportion of fine particles that trap air during compression, or excessively high turret speed that does not allow adequate time for air to escape from the compact; remediation typically involves increasing binder content, adjusting the granule loss-on-drying to within an optimal two to four per cent range, reducing turret speed, or introducing a pre-compression stage to allow gradual air expulsion before the main compression event.

Sticking and picking, in which material adheres to the punch faces, most frequently results from inadequate lubrication, damaged or worn punch surfaces, or excessive moisture content within the granulation, and is generally addressed by increasing magnesium stearate concentration, polishing or replacing the affected punches, or re-drying the granulation to reduce ambient moisture uptake. Weight variation beyond acceptable limits typically reflects poor powder flow, electrostatic charging of fine particles, or uneven hopper feeding, and is remediated through the addition of a glidant such as colloidal silicon dioxide, the introduction of anti-static measures, or the installation of a forced-feed mechanism to ensure consistent die filling.

Low tablet hardness generally indicates insufficient binder content, selection of an inappropriate binder polymer, or inadequate compression force, and is addressed through an increase in binder concentration, reformulation with a more effective binder such as polyvinylpyrrolidone, or an increase in applied compression force, with careful attention paid to avoiding the opposite extreme of over-compression, which can itself induce capping. Content non-uniformity most commonly arises from inadequate blending time, agglomeration of the active ingredient, or segregation of formulation components during handling, and is remediated through extended blend times, co-milling of the active ingredient to reduce agglomerate size, conversion to a wet granulation process that physically binds the drug to the granule matrix, or, in more difficult cases, a reduction in batch size to improve blend homogeneity.

Dissolution failure, representing perhaps the most consequential tablet defect given its direct implication for bioavailability, may result from an unanticipated polymorphic transition of the active ingredient during processing, over-lubrication with a hydrophobic lubricant that impedes water ingress into the tablet matrix, or use of an inappropriate dissolution medium pH relative to the ionisation behaviour of the drug, and troubleshooting accordingly requires X-ray powder diffraction confirmation of polymorphic form stability, a reduction in lubricant blending time or concentration, or reassessment of the dissolution medium against the drug's established pKa and pH-solubility profile. Film coating defects such as coat peeling or mottled colour distribution typically reflect insufficient film adhesion, excessive spray rate relative to drying capacity, or uneven spray pattern within the coating pan, and are addressed through reduced spray rate, increased inlet air temperature, optimisation of applied coat weight, or adjustment of pan rotation speed and nozzle configuration.